Fidelity Advisor Biotechnology Fund is a registered fund series of Fidelity Advisor Series VII (series S000005321). Net assets $1.9B as of 2026-04-30.
Showing 15 of 98 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| ABBVIE INC | — | $282.2M | 1482.70% |
| ALNYLAM PHARMACEUTICALS INC | — | $105.1M | 552.01% |
| GILEAD SCIENCES INC | — | $103.2M | 542.30% |
| INSMED INC | — | $66.7M | 350.68% |
| COGENT BIOSCIENCES INC | — | $65.7M | 345.01% |
| DIANTHUS THERAPEUTICS INC | — | $64.1M | 336.77% |
| SPYRE THERAPEUTICS INC | — | $63.4M | 333.17% |
| ASCENDIS PHARMA A/S | — | $61.8M | 324.45% |
| ARGENX SE | — | $60.3M | 317.06% |
| BIOGEN INC | — | $55.7M | 292.47% |
| ORUKA THERAPEUTICS INC | — | $50.4M | 265.03% |
| Fidelity Revere Street Trust | — | $47.8M | 251.02% |
| AMGEN INC | — | $46.8M | 245.77% |
| VAXCYTE INC | — | $43.7M | 229.65% |
| REVOLUTION MEDICINES INC | — | $43.2M | 226.78% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $1.9B |
| 2026-01-31 | $1.9B |
| 2025-10-31 | $1.7B |
| 2025-07-31 | $1.4B |
| 2025-04-30 | $1.4B |
| 2025-01-31 | $1.5B |
| 2024-10-31 | $1.9B |
| 2024-07-31 | $1.8B |